Showing results (261-270 of 1,630) with videos related to

Sort By:
Pageof 163
Human Mutation|January 1, 1995
Somatic spectrum of cancer-associated single basepair substitutions in the TP53 gene is determined mainly by endogenous mechanisms of mutation and by selectionM Krawczak, B Smith-Sorensen, J Schmidtke, et al.
Thrombosis and Haemostasis|April 1, 1997
Decrease in factor VII coagulant activity during percutaneous transluminal coronary angioplasty by heparin-mediated lipolytic actionM Mukherjee, M F Scully, V V Kakkar, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 1, 1994
Combined factor VIII/factor XI deficiency may cause intra-familial clinical variability in haemophilia A among Ashkenazi JewsL P Berg, D Varon, U Martinowitz, et al.
Lancet (London, England)|October 1, 1994
Low-molecular weight heparin versus aspirin and dipyridamole after femoropopliteal bypass graftingR A Edmondson, A T Cohen, S K Das, et al.
Thrombosis and Haemostasis|February 12, 1998
Functional characterization of PM6/13, a beta3-specific (GPIIIa/CD61) monoclonal antibody that shows preferential inhibition of fibrinogen binding over fibronectin binding to activated human plateletsY Patel, S Rahman, A Siddiqua, et al.
British Journal of Clinical Pharmacology|January 1, 1983
Haemodynamic and metabolic effects of dazoxiben at rest and during atrial pacingP S Kiff, G Bergman, L Atkinson, et al.
Thrombosis Research|June 1, 1984
Selenium enhances prostacyclin production by cultured endothelial cells: possible explanation for increased bleeding times in volunteers taking selenium as a dietary supplementR Schiavon, G E Freeman, G C Guidi, et al.
Indian Heart Journal|March 21, 2001
Low molecular weight heparin for treatment of acute myocardial infarction (FAMI): Fragmin (dalteparin sodium) in acute myocardial infarctionV V Kakkar, S S Iyengar, F De Lorenzo, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 16, 2000
Expression, localization, and activity of tissue factor pathway inhibitor in normal and atherosclerotic human vesselsJ Crawley, F Lupu, A D Westmuckett, et al.
Thrombosis and Haemostasis|December 29, 2000
In situ analysis of tissue factor-dependent thrombin generation in human atherosclerotic vesselsA D Westmuckett, C Lupu, D A Goulding, et al.
Pageof 163